why choose us

Clinical Trials Search

Showing 19,530 of 132,963 result(s)
A Study of TAVO412 in Patients With Cancer

Status: Completed

Condition: Cancer

Interventions: Biologic

Date: 2022-09-14

Immunogenicity of HPV Vaccine in Transplant Recipients.

Status: Completed

Condition: Chronic Kidney Diseases

Interventions: Patients will be scheduled to receive 3-dose 9vHPV vaccination (vaccination at enrollment [time 0], 2 months [+ 6 weeks], and 6 months [+ 6 weeks] per

Date: 2022-09-14

Treatment of Calcific Total Occlusions in Peripheral Artery Disease

Status: Completed

Condition: Chronic Total Occlusion of Artery of the Extremities

Interventions: Use of the SoundBite Crossing System to cross calcified chronic total occlusions

Date: 2022-09-14

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism

Status: Completed

Condition: Chronic Kidney Disease stage3

Interventions: CTAP101 Capsules is an extended-release (ER) oral formulation of calcifediol which was approved as Rayaldee® ER Capsules in June 2016 by the United St

Date: 2022-09-13

The Role of the Locus Coeruleus in Age-related Distractibility

Status: Completed

Condition: Aging

Interventions: An adaptive at-home tablet-based program that includes variants of the Flanker Task, the Stroop Task, and a Visual Tracking Task.
Each session of

Date: 2022-09-13

Using Machine Learning to Optimize User Engagement and Clinical Response to Digital Mental Health Interventions

Status: Completed

Condition: Anxiety Disorders and Symptoms

Interventions: This is a cognitive behavioral treatment (CBT) for emotional disorders.
This transdiagnostic intervention consists of eight modules and can be ef

Date: 2022-09-13

The Effects of ECMO on the Pharmacokinetics of Hydromorphone

Status: Completed

Condition: Extracorporeal Membrane Oxygenation

Interventions: Hydromorphone was administered intravenously at a rate of 0.03 mg;kg;h for 72 h for analgesia.
Blood samples were collected before admi

Date: 2022-09-13

Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression

Status: Completed

Condition: Postpartum Depression

Interventions: Enrolled subjects will receive a 60-hour infusion of Brexanolone (BRX) according to FDA approved protocol for administration.
A programmable peri

Date: 2022-09-13

Drug Concentrations in Breast Milk and Prediction of Blood Levels of the Breastfed Infants

Status: Completed

Condition: Breast Feeding

Interventions: This is a cohort study of pharmacokinetics of drugs in milk.
Participants in the group are those breastfeeding women on the listed drugs at stead

Date: 2022-09-13

Study to Evaluate the Safety, Tolerability, and PK of Pacritinib

Status: COMPLETED

Condition: Hepatic Impairment

Interventions: Subjects will receive 200 mg BID pacritinib for 14 days.

Date: 2022-09-13